http://www.nytimes.com/2011/08/09/us/09healy.htmlDr. Healy’s curriculum vitae was a compendium of academic and professional achievements that in its cold detail omitted a central fact: her relentless attack on the misperception that heart attacks were men’s problems. Heart disease was by far the leading killer of American women, who accounted for nearly 40 percent of its victims. Women’s groups had long sought a greater focus on women’s coronary health, cancers and the role of hormonal changes and therapy.
Dr. Healy cracked the whip on bureaucrats, recruited new talent, expanded the Human Genome Project and reversed policies that, like the medical establishment, had focused largely on men’s health and virtually excluded women from clinical trials. She mandated the inclusion of women in trials wherever appropriate
She began the Women’s Health Initiative, a $625 million study of the causes, prevention and treatment of cardiovascular diseases, osteoporosis and cancer in middle-aged and older women. Long after her tenure, it continued yielding important findings. In 2002, it found that prolonged combined estrogen and progestin hormone replacement therapy in postmenopausal women increased risks of breast cancer, stroke and heart attacks.
“Dr. Healy’s stubborn insistence that the N.I.H. concern itself with women’s health was not broadly supported at the time,” Anne M. Dranginis, an associate professor of biological sciences at St. John’s University, wrote in a 2002 Op-Ed article in The New York Times. “Had Dr. Healy not championed research on women’s health, how much longer would healthy women have been encouraged to take hormone drugs?”